IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Login to save this paper or follow this series

Mercado de Medicamentos, Regulación y Políticas Públicas

  • Hernán Jaramillo Salazar

    ()

  • José Manuel Restrepo Abondano

    ()

  • Catalina Latorre Santos

    ()

Este documento tiene el propósito de analizar el documento de Fedesarrollo: "Efectos económicos y sociales de la regulación sobre la industria farmacéutica colombiana: El caso de los estudios de bioequivalencia y biodisponibilidad de los secretos empresariales y las buenas prácticas de manufactura" Zuleta and Junca (2001), tanto en sus aspectos conceptuales y metodológicos, como de resultados. El estudio se centra en tres aspectos esenciales: la exigencia de estudios de biodisponibilidad y bioequivalencia (ByB) relacionados con la obtención-renovación de registros sanitarios por parte de la industria farmacéutica; el secreto empresarial relacionado con la calificación de la información que sustenta los registros, y la aplicación de las medidas relacionadas con las buenas prácticas de manufactura (BPM).

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.urosario.edu.co/FASE1/economia/documentos/pdf/bi38.pdf
Download Restriction: no

Paper provided by UNIVERSIDAD DEL ROSARIO in its series BORRADORES DE INVESTIGACIÓN with number 004328.

as
in new window

Length: 26
Date of creation: 31 Aug 2003
Date of revision:
Handle: RePEc:col:000091:004328
Contact details of provider:

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:

as in new window
  1. Lanjouw, Jean O. & Cockburn, Iain M., 2001. "New Pills for Poor People? Empirical Evidence after GATT," World Development, Elsevier, vol. 29(2), pages 265-289, February.
  2. Frank Lichtenberg, 2002. "Benefits and Costs of Newer Drugs: An Update," NBER Working Papers 8996, National Bureau of Economic Research, Inc.
  3. Mattias Ganslandt & Keith E. Maskus & Eina V. Wong, 2001. "Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal," The World Economy, Wiley Blackwell, vol. 24(6), pages 779-795, 06.
  4. Arora, Ashish, 1996. "Contracting for tacit knowledge: the provision of technical services in technology licensing contracts," Journal of Development Economics, Elsevier, vol. 50(2), pages 233-256, August.
  5. Miller, Richard D. & Frech, Ted, 2002. "The Productivity of Health Care and Pharmaceuticals: Quality of Life, Cause," University of California at Santa Barbara, Economics Working Paper Series qt4b55f1xp, Department of Economics, UC Santa Barbara.
Full references (including those not matched with items on IDEAS)

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

When requesting a correction, please mention this item's handle: RePEc:col:000091:004328. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Paola Villalobos)

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.